The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
Abstract The prevalence of obesity increases worldwide. Treating obesity and its associated health problems has a significant economic impact on health care systems. The unsatisfactory long-term outcomes observed in the obesity treatment are due to its complex pathophysiology and the inherent diffic...
Main Authors: | Marcio C. Mancini, Maria Edna de Melo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13098-017-0242-0 |
Similar Items
-
Gglucagon-like peptide-1 analogue liraglutide (Saxenda®): mechanism of action, efficacy for the treatment of obesity
by: Tatiana I. Romantsova
Published: (2018-04-01) -
Comparison of the effects of liraglutide and sibutramine in obese patients
by: G. A. Matveev, et al.
Published: (2021-07-01) -
Liraglutide and Exercise: A Possible Treatment for Obesity?
by: Ana Paula Azevêdo Macêdo, et al.
Published: (2022-08-01) -
Ejaculate quality indicators of men with asthenozoospermia and asthenoteratozoospermia by treatment of obesity with liraglutide
by: D. N. Bobkov, et al.
Published: (2021-10-01) -
Efficacy of Intragastric Balloon versus Liraglutide as Bridge to Surgery in Super-Obese Patients
by: Gennaro Martines, et al.
Published: (2023-08-01)